Abstract | AIM: Oxidative stress plays a pivotal role in the transition from simple steatosis to non- alcoholic steatohepatitis (NASH). Probucol is a lipid-lowering agent with strong antioxidant properties, and is reported to be effective for the treatment of NASH in several studies. The aim of the present study was to evaluate the efficacy of probucol for the treatment of NASH with dyslipidemia. METHODS: RESULTS: CONCLUSION:
|
Authors | Tomokazu Ishitobi, Hideyuki Hyogo, Hironori Tokumo, Koji Arihiro, Kazuaki Chayama |
Journal | Hepatology research : the official journal of the Japan Society of Hepatology
(Hepatol Res)
Vol. 44
Issue 4
Pg. 429-35
(Apr 2014)
ISSN: 1386-6346 [Print] Netherlands |
PMID | 23607264
(Publication Type: Journal Article)
|
Copyright | © 2013 The Japan Society of Hepatology. |